We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Ninety percent of MDD patients who did not adequately respond to pharmaceutical treatment showed improvement when using the device, the company said. Read More